SWIXX BioPharma
SWIXX BioPharma is a Healthcare & Life Sciences startup based in All, most recent round Series C+, 2 tracked investors.
About SWIXX BioPharma
SWIXX BioPharma is a company founded in 2014 headquartered in All. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
SWIXX BioPharma is a specialized distributor of prescription (Rx) and over‑the‑counter (OTC) medicinal products, focusing on rare diseases in Central and Eastern Europe. It partners with biotech and pharmaceutical companies to commercialize products and provide local market presence in countries where multinationals do not operate.
Explore SWIXX BioPharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.